Related Experiment Video
Updated: Jan 12, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Vascular cognitive impairment and dementia in old age: cognition and beyond
Ana Charlotte Menart1, Lisanne Tap2, Frank J Wolters1,3
1Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Insights
Vascular cognitive impairment and dementia (VCID) affects aging individuals, often linked to cardiovascular risks. Management focuses on preventing risk factors and combined cognitive-motor interventions to maintain abilities.
Area of Science:
- Gerontology
- Neurology
- Cardiology
Background:
- Vascular cognitive impairment and dementia (VCID) is a prevalent condition in the aging population.
- VCID arises from altered vascular perfusion or function, including strokes, hemorrhages, and small vessel disease.
- Cardiovascular risk factors like hypertension, hyperlipidemia, diabetes, smoking, and atrial fibrillation accelerate VCID development.
Purpose of the Study:
- To provide an overview of VCID, focusing on modifiable risk factors and their impact on cognitive and motor functions.
- To highlight recent advancements in preventative risk factor management for VCID.
- To explore combined cognitive-motor interventions for maintaining cognitive and functional abilities in individuals with VCID.
Main Methods:
- Review of selected studies on VCID published in Age and Ageing.
- Analysis of the impact of modifiable risk factors on cognitive and motor symptoms.
- Examination of current preventative strategies and emerging interventions for VCID.
Main Results:
- VCID symptoms vary based on affected brain regions and blood flow disruption.
- Early signs include slowed thinking, executive dysfunction, concentration difficulties, confusion, and mood/behavioral changes.
- Motor function disturbances (gait, balance) are recognized as early VCID features, potentially worsening with multi-domain impairment.
Conclusions:
- Currently, no cure exists for VCID; clinical focus is on timely prevention, supportive care, and management.
- Modifiable risk factors significantly impact motor and cognitive symptoms in VCID.
- Combined cognitive-motor interventions show promise for preserving cognitive and functional abilities.
Abstract:
Vascular cognitive impairment and dementia (VCID) is common in the ageing population. VCID is often the cause of alterations in vascular perfusion or function, reflected for example in strokes, haemorrhages, and small vessel disease. The risk of developing VCID is accelerated by the presence of cardiovascular risk factors like hypertension, hyperlipidemia, diabetes mellitus, smoking, and atrial fibrillation. Symptoms of VCID vary depending on the brain regions affected and the extent of blood flow disruption. Common early signs include slowed thinking, difficulty planning or organizing, trouble concentrating, confusion, and changes in mood or behaviour. Motor function disturbances in gait and balance are increasingly recognized as early features, and functional consequences may well be aggravated in the presence of multi-domain impairment in motor function as well as cognition. While some patients experience sudden onset of these symptoms following a cerebrovascular event, many experience a gradual progression of symptoms due to cerebral small vessel damage. In the absence of a cure for VCID, emphasis on clinical treatment is on timely preventive interventions as well as supportive care and management. The collection of selected studies on VCID published in Age and Ageing provides an overview of the impact of modifiable risk factors on motor function impairment as well as cognitive symptoms, and points towards developments in preventative risk factor management and recent combined cognitive-motor interventions aimed at maintaining cognitive and functional ability.
Related Concept Videos
Cognitive Development During Adulthood
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients

